摘要
“互联网+医药”经济催生了巨大的医药产值,但在这利好势头下,医药网购消费者的衍生权利受损和保障不力问题日渐凸显。本文在梳理医药网购消费者衍生权利种类的基础上,探讨其保护中存在的问题,并从国家、经营者和消费者三方视角分析其问题根源,进而提出完善我国医药网购消费者衍生权利保护的设想。
The Internet plus medicine economy has spawned a huge pharmaceutical output.However,in this favorable context,damage to and ineffective protection of the derivative rights of online shopping consumers become increasingly serious.Having sorted out the types of derivative rights of online shopping consumers of pharmaceuticals,this paper discusses the problems existing in the current protection of these derivative rights,and analyze the root causes of these problems from the perspective of the state,industry and consumers,and then puts forward suggestions to improve the protection of these rights in China.
作者
王洪婧
王薇
马勇
胡友利
张建华
WANG Hongjing("Healthy Shandong"Major Social Risk Forecasting and Governance Collaborative Innovation Center,Weifang Medical University,Weifang,Shandong,261053,China)
出处
《医学与社会》
北大核心
2021年第10期123-128,共6页
Medicine and Society
基金
教育部人文社会科学研究规划基金资助项目,编号为19YJC820043
山东省重点研发计划(软科学项目),编号为2019RKB14115
教育部产学合作协同育人项目,编号为201902195005
山东省社会科学普及项目,编号为2019-SKZZ-30
山东省研究生导师指导能力提升项目,编号为SDYY18148。
关键词
互联网+
医药网购
消费者
衍生权利
Internet Plus
Pharmaceuticals Online Purchase
Consumer
Derivative Rights